Search

everythinglearnresearchcommunity

for

Search:↓

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Natural killer cells play a key role in autoimmune skin diseases like pemphigus vulgaris.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Wearing a frozen glove during chemotherapy can reduce nail and skin problems but may not be comfortable for everyone.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

The April 2016 JEADV issue covered various dermatology topics, including psoriasis, psoriatic arthritis, mTOR inhibitors, autoimmune diseases, photodynamic therapy, viral DNA in skin diseases, chronic hand eczema, and female hair loss.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Cellulite may be linked to low adiponectin, isotretinoin with UVB can treat psoriasis effectively, permanent alopecia post-chemotherapy resembles a unique hair loss, deodorants may cause fragrance allergies, desmoplastic melanoma is becoming more common, and intensive UVB treatment can give long-term psoriasis remission.